FinDogFinDog
Monday, October 12, 2026Closing data · 4:00 PM ET
English
Log in

Daily Wrap

Published after every US market close · Markets, news, rates and FX on one pageSubscribe
2026-10-05

Stocks Rise as Industrials Lead, but Breadth Stays Narrow

Stock Heatmap
Size = market cap (square-root scaled within sectors) · Color = day's change · Click a sector name to zoom, a tile to open the stock
Zoom into Information TechnologyInformation TechnologyNVDA+2.1%AAPL-0.2%MSFT+1.5%AVGO+2.1%MU-1.0%AMD-0.3%INTC-2.6%PLTR+0.3%CSCO+0.6%ORCL+0.1%AMAT+0.4%LRCX-0.5%DELL-1.8%PANW+0.9%CRWD+1.0%ANET-0.2%TXN+0.4%KLAC-0.0%MRVL-0.4%SNDK-0.9%SHOP+5.8%APH+0.4%IBM-0.5%ADI+0.5%CRM-2.1%QCOM-2.2%WDC+6.3%STX+4.5%NOWFTNTGLW-2.9%ACN-1.9%DDOG-0.3%LITE+0.6%SNPS-0.3%HPE-1.4%CDNSADBEINTUMSIMPWRKEYSMSTRCIENTELTERMCHPWDAYROPJBLZoom into Communication ServicesCommunication ServicesGOOGL+0.9%GOOG+1.0%META+1.9%NFLX+0.7%DIS+1.4%VZ-0.1%TMUS+0.6%TAPPCMCSALYVTTWOTKORDDTECHOFOXAFOXOMCNWSZoom into FinancialsFinancialsBRK.BJPMVMABACMSGSWFCCAXPZoom into IndustrialsIndustrialsSPCX+7.6%Zoom into Consumer DiscretionaryConsumer DiscretionaryAMZN-0.1%TSLA+2.2%HD-0.6%MCDTJXSBUXABNBMELIMARDASHZoom into Health CareHealth CareLLY+0.0%JNJ-1.2%ABBVMRKUNHTMOZoom into Consumer StaplesConsumer StaplesWMT+0.8%COSTKOZoom into EnergyEnergyXOM-0.0%CVXZoom into UtilitiesUtilitiesZoom into Real EstateReal EstateZoom into MaterialsMaterials
−4% 0 +4%
Market Summary

Market & SentimentMajor indexes closed higher, with the Nasdaq 100 up 0.88% and the S&P 500 up 0.67%. The Russell 2000 gained 0.66%. Yet breadth was mixed: 316 advancers against 178 decliners, and only 27.6% of stocks above their 50-day average. New highs (18) barely exceeded new lows (15), suggesting a cautious tone beneath the surface.

Sectors & StocksIndustrials led with a 2.07% gain, followed by communication services (+1.09%) and materials (+1.01%). Real estate was the sole laggard, down 0.44%. Among large caps, MercadoLibre jumped 9.67%, SpaceX rose 7.63% on a Morgan Stanley bullish call, and Moderna gained 6.95% ahead of its Nasdaq-100 inclusion. Bristol Myers Squibb fell 3.83% and Merck lost 3.3%.

Rates, FX & CryptoTreasury yields edged higher, with the 10-year up 3 basis points to 5.31% and the 2-year up 1 bp to 4.84%. The 2s10s spread remained at 47 bps. The dollar was little changed against the yuan (USD/CNY flat) and slightly stronger versus the euro (EUR/USD -0.19%). Bitcoin slipped 0.83% to $85,784, and Ether fell 0.81%.

Earnings & AnnouncementsNo major earnings reports today. FinDog made no view changes. In corporate news, Moderna will join the Nasdaq-100 before the open on October 9, replacing Warner Bros. Discovery. AbbVie and Genmab announced positive Phase 3 results for epcoritamab in DLBCL. Eli Lilly received FDA orphan drug designation for its pancreatic cancer drug olomorasib. Constellation Brands reports after the close tomorrow.

What to Watch Next Trading Day
  • Constellation Brands earnings after the close
  • Moderna's Nasdaq-100 inclusion on October 9
  • Any follow-through in industrials and tech
  • Treasury yield moves and dollar direction
Top News
  1. Microsoft gets bullish call from Melius on AI strategy
    Melius Research is optimistic on Microsoft's AI and cloud expansion, arguing AI fears could benefit leaders. The call highlights enterprise adoption as a key growth driver.
    MSFTYahoo10-05 16:49 UTC
  2. SpaceX shares rise as Morgan Stanley reiterates $300 target
    Morgan Stanley maintained its overweight rating and $300 price target on SpaceX, calling the stock undervalued. Shares rose 8% on the news.
    SPCXYahoo10-05 15:10 UTC
  3. Moderna to join Nasdaq-100, replacing Warner Bros. Discovery
    Nasdaq announced Moderna will join the Nasdaq-100 before the open on October 9. The stock surged ahead of the index inclusion.
    MRNAYahoo10-05 19:30 UTC
  4. AbbVie and Genmab report positive Phase 3 lymphoma data
    Epcoritamab combined with R-CHOP showed significant improvement in progression-free survival in newly diagnosed DLBCL. The results support a potential regulatory path.
    ABBVYahoo10-05 18:54 UTC
  5. Eli Lilly gets FDA orphan drug status for pancreatic cancer drug
    The FDA granted orphan drug designation to Eli Lilly's olomorasib for pancreatic cancer. The designation provides incentives including tax credits and exclusivity.
    LLYYahoo10-05 17:34 UTC
  6. UnitedHealth exits some Medicare Advantage plans for 2027
    UnitedHealth is exiting select Medicare Advantage plans for 2027 due to rising medical costs. The move will reshape its membership mix.
    UNHYahoo10-05 14:48 UTC
  7. TSMC hits record as Musk confirms early Terafab talks
    Elon Musk confirmed early talks between his Texas chip venture and TSMC. TSMC shares rose 2% to a record, while Broadcom also gained 2%.
    AVGOYahoo10-05 17:02 UTC
  8. Qualcomm and Arm begin new trial over chip testing tools
    Qualcomm claims Arm withheld chip testing tools required under their contract. The trial could impact licensing relationships in the semiconductor sector.
    QCOMYahoo10-05 16:22 UTC

Stories are selected and summarized by AI from the day's news coverage. Click a headline to read the original. Not investment advice.

Archive10-1210-0910-0810-0710-0610-0510-0210-0109-3009-29